Adverum Biotechnologies Inc. (ADVM) |
|
9.53 0.4 (4.38%)
|
11-19 12:25 |
|
Open: |
9.21 |
Pre. Close: |
9.13 |
|
High:
|
9.575 |
Low:
|
9.02 |
|
Volume:
|
374,771 |
Market Cap:
|
616M |
|
|
|
|
Adverum Biotechnologies Inc is a gene therapy company committed to discovering and developing novel medicines that can offer potentially life-changing therapeutic benefit to patients living with rare diseases or diseases of the eye. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
9.412 - 9.458 |
9.458 - 9.496 |
|
Low:
|
8.785 - 8.847 |
8.847 - 8.896 |
|
Close:
|
9.043 - 9.137 |
9.137 - 9.213 |
|
Technical analysis |
as of: 2019-11-19 11:55:35 AM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 11.17 One year: 13.05 |
| Support: |
Support1: 7.50 Support2: 6.23 |
| Resistance: |
Resistance1: 9.56 Resistance2: 11.17 |
| Pivot: |
8.44 |
| Moving Average: |
MA(5): 9.22 MA(20): 8.12
MA(100): 9.80  MA(250): 7.36 |
| MACD: |
MACD(12,26): 0.63 Signal(9): 0.48 |
| Stochastic oscillator: |
%K(14,3): 96.31 %D(3): 93.30 |
| RSI: |
RSI(14): 68.78 |
| 52-week: |
High: 16.38 Low: 2.81 Change(%): 163.8 |
| Average Vol(K): |
3-Month: 203159 10-Days: 90183 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.ADVM has closed below upper band by 14.1%. Bollinger Bands are 26.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
2019-11-12
Stock Analysts’ Upgrades for November, 12th (ACAD, ADVM, AOBC, ATSG, BIDU, CLLS, DXPE, FEYE, FHB, FSBW)
Stock Analysts’ upgrades for Tuesday, November 12th: ACADIA Pharmaceuticals (NASDAQ:ACAD) was upgraded by analysts at BidaskClub from a sell rating to a hold rating. Adverum Biotechnologies (NASDAQ:ADVM) was upgraded by analysts at BidaskClub from a hold rating to a buy rating. American Outdoor Brands (NASDAQ:AOBC) was upgraded by analysts at BidaskClub from a buy rating […]
2019-09-30
Adverum Biotechnologies Enters Oversold Territory
Adverum Biotechnologies has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
